1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NRXN2 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA MRPL24 CTRPv2 pan-cancer AAC -0.17 1e-07
mRNA SLC8A2 CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA DYRK1B CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA UNC79 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA C18orf32 CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA KIF1A CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA IRAK1BP1 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA DPYSL5 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA ACVR2B CTRPv2 pan-cancer AAC 0.19 1e-07
Download CSV